9-methyl-6,9-diazaspiro[4.5]decane, 95.0%, 250mg

(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(aminomethyl)tetrahydrofuran-3,4-diol, 95+%, 5mg

3,6-dimethylisoxazolo[5,4-d]pyrimidin-4(5H)-one, 95.0%, 250mg

N,N-Diciclohexilcarbodiimida (DCC), 100 g, >=98 %, envase de vidrio

Glycyl-L-valine>99.0%(T)1g

Espátulas dobles curvadas, 210 mm, 9 mm, 1 Pieza

4-(4-Methoxybenzyl)-3-thiosemicarbazide, 5g

5,6,7,8-Tetrahydro-2-(4-morpholinylmethyl)[1]benzothieno[2,3-d]pyrimidin-4(1H)-one, 250mg

4-Fluoro-2-(methylsulfonyl)-1-nitrobenzene, 95.0%, 1g

2-Methoxy-4-ethylphenol>98.0%(GC)25mL

Methyl 4,6-dichloropyridazine-3-carboxylate, 99.0%, 10g

Ethyl 4-amino-6-chloro-5-fluoronicotinate, 97%, 25g

(-)-Corey Lactone 4-Phenylbenzoate>98.0%(HPLC)1g